Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting

AIDS and Behavior

Volumn 15, Issue 2, 2011, Pages 422-431

  Müller, Alexandra D ^a,b   Jaspan, Heather B ^b,c,d   Myer, Landon ^d,e   Lewis Hunter, Ashley ^f   Harling, Guy ^b,g   Bekker, Linda Gail ^b   Orrell, Catherine ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Harvard Medical School ^*  (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Monitoring methods; Pediatrics; Resource limited settings

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AMBULATORY MONITORING; ARTICLE; CAREGIVER; CHILD; COMPARATIVE STUDY; DRUG MONITORING; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFORMATION PROCESSING; INSTRUMENTATION; LONGITUDINAL STUDY; MALE; METHODOLOGY; PAIN ASSESSMENT; PATIENT COMPLIANCE; PHARMACY; PRESCHOOL CHILD; QUESTIONNAIRE; SOUTH AFRICA; STANDARD; STATISTICS; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; AUTOMATIC DATA PROCESSING; CAREGIVERS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MONITORING, AMBULATORY; PAIN MEASUREMENT; PHARMACIES; QUESTIONNAIRES; SOUTH AFRICA; VIRAL LOAD;

EID: 79951671308     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9825-6     Document Type: Article

References (32)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global HIV/AIDS epidemic 2008. Geneva: UNAIDS; 2008.
2. K Patel MA Hernan PL Williams, et al. 2008 Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting Clin Infect Dis 46 11 1751 1760 1:CAS:528:DC%2BD1cXnsVOhtbw%3D 10.1086/587900 18426371 (Pubitemid 351706777)
3. A Judd K Doerholt PA Tookey, et al. 2007 Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care Clin Infect Dis 45 7 918 924 10.1086/521167 17806062 (Pubitemid 47580389)
4. TM Candiani J Pinto CA Cardoso, et al. 2007 Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil Cad Saude Publica 23 Suppl 3 S414 S423 17992347
5. DR Bangsberg FM Hecht ED Charlebois, et al. 2000 Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 14 4 357 366 1:CAS:528:DC%2BD3cXis1egu7s%3D 10.1097/00002030- 200003100-00008 10770537 (Pubitemid 30182431)
6. S Boni E Pontali P De Gol P Pedemonte D Bassetti 2000 Compliance to combination antiretroviral therapy in HIV-1 infected children Int J Antimicrob Agents 16 3 371 372 1:CAS:528:DC%2BD3cXot12ktLY%3D 10.1016/S0924-8579(00)00256-9 11091067
7. J Farley S Hines A Musk S Ferrus V Tepper 2003 Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping J Acquir Immune Defic Syndr 33 2 211 218 10.1097/00126334-200306010-00016 12794557 (Pubitemid 36793158)
8. S Martin DK Elliott-DeSorbo PL Wolters, et al. 2007 Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents Pediatr Infect Dis J 26 1 61 67 10.1097/01.inf.0000250625.80340.48 17195708 (Pubitemid 46045754)
9. RG Steele B Anderson B Rindel, et al. 2001 Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs AIDS Care 13 5 617 629 1:STN:280:DC%2BD3Mritl2mtw%3D%3D 10.1080/09540120120063241 11571008 (Pubitemid 32928069)
10. RC Vreeman SE Wiehe EC Pearce WM Nyandiko 2008 A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries Pediatr Infect Dis J 27 8 686 691 10.1097/INF.0b013e31816dd325 18574439
11. AD Muller S Bode L Myer P Roux N von Steinbuchel 2008 Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa Pediatr Infect Dis J 27 3 257 262 10.1097/INF.0b013e31815b1ad4 18277933
12. A Elise AM France WM Louise, et al. 2005 Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d'Ivoire J Acquir Immune Defic Syndr 40 4 498 500 10.1097/01.qai.0000168180.76405.5f 16280708 (Pubitemid 41669187)
13. M Mukhtar-Yola S Adeleke D Gwarzo Z Ladan 2006 Preliminary investigation of adherence to antiretroviral therapy among children in Aminu Kano Teaching Hospital, Nigeria Afr J AIDS Res 5 2 141 144 10.2989/16085900609490374 (Pubitemid 44515419)
14. N Nabukeera-Barungi I Kalyesubula A Kekitiinwa J Byakika-Tusiime P Musoke 2007 Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala Ann Trop Paediatr 27 2 123 131 10.1179/146532807X192499 17565809 (Pubitemid 47629159)
15. AD Muller L Myer H Jaspan 2009 Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy Clin Infect Dis 48 1 e3 e5 10.1086/595553 19025495
16. J Shuter JA Sarlo TJ Kanmaz RA Rode BS Zingman 2007 HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95% J Acquir Immune Defic Syndr 45 1 4 8 1:CAS:528:DC%2BD2sXksFOltro%3D 10.1097/QAI.0b013e318050d8c2 17460469 (Pubitemid 46684437)
17. R Gross WB Bilker H Wang J Chapman 2008 How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clin Trials 9 3 202 206 10.1310/hct0903-202 18547907 (Pubitemid 351892874)
18. JB Nachega M Hislop DW Dowdy, et al. 2006 Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults J Acquir Immune Defic Syndr 43 1 78 84 10.1097/01.qai.0000225015.43266.46 16878045 (Pubitemid 44306492)
19. R Grossberg R Gross 2007 Use of pharmacy refill data as a measure of antiretroviral adherence Curr HIV/AIDS Rep 4 4 187 191 10.1007/s11904-007-0027-4 18366950
20. KM Berg JH Arnsten 2006 Practical and conceptual challenges in measuring antiretroviral adherence J Acquir Immune Defic Syndr 43 Suppl 1 S79 S87 17133207
21. JM Simoni A Montgomery E Martin M New PA Demas S Rana 2007 Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management Pediatrics 119 e1371 e1383 10.1542/peds.2006-1232 17533177 (Pubitemid 46871324)
22. Department of Health South Africa. National HIV and syphilis antenatal prevalence survey, South Africa, 2007. Pretoria: Department of Health; 2008.
23. Department of Health South Africa. National antiretroviral treatment guidelines 2004. Available at http://www.doh.gov.za/docs/factsheets/guidelines/ artguidelines04/sec2.pdf. Accessed 26 July 2010.
24. AE Deschamps VD Graeve E van Wijngaerden, et al. 2004 Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System AIDS Patient Care STDs 18 11 644 657 10.1089/apc.2004.18.644 15633262 (Pubitemid 39579158)
25. CA Bova KP Fennie GJ Knafl KD Dieckhaus E Watrous AB Williams 2005 Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations AIDS Behav 9 1 103 110 10.1007/s10461-005-1685-0 15812617 (Pubitemid 40562187)
26. JH Oyugi J Byakika-Tusiime ED Charlebois, et al. 2004 Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting J Acquir Immune Defic Syndr 36 5 1100 1102 1:CAS:528:DC%2BD2cXlsFemu78%3D 10.1097/00126334-200408150-00014 15247564 (Pubitemid 38989377)
27. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4):e61.
28. M-A Davies A Boulle T Fakir J Nuttall B Eley 2008 Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study BMC Pediatr 8 34 10.1186/1471-2431-8-34 18771599
29. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
30. G Harling L-G Bekker R Wood 2007 Cost of a dedicated ART clinic SA Med J 97 8 593 596 (Pubitemid 47412019)
31. JM Simoni AE Kurth CR Pearson DW Pantalone JO Merrill PA Frick 2006 Self-reported measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management AIDS Behav 10 3 227 245 10.1007/s10461-006-9078-6 16783535
32. Müller AD, Bode S, Myer L, Stahl J, von Steinbüchel N. Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa. AIDS Care. 2010;19:1-10 (Epub ahead of print).